# Nuclide record anzup (institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/institutions/anzup/>
  a schema:MedicalOrganization ;
  nuclide:kind "institution" ;
  schema:identifier "anzup" ;
  schema:name "ANZUP Cancer Trials Group"@en ;
  schema:alternateName "Australian and New Zealand Urogenital and Prostate Cancer Trials Group"@en, "ANZUP"@en ;
  schema:description "The Australian genitourinary trials group behind TheraP and proPSMA, the trials that put PSMA imaging and lutetium-PSMA therapy on the map."@en ;
  schema:url <https://nuclide.cc/institutions/anzup/>, <https://anzup.org.au> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://anzup.org.au>, <https://anzup.org.au/trials/> ;
  schema:addressCountry "AU" ;
  schema:addressLocality "Sydney" ;
  schema:latitude "-33.868"^^xsd:decimal ;
  schema:longitude "151.209"^^xsd:decimal ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/rcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-therapy/>, <https://nuclide.cc/technologies/psma-pet/> ;
  nuclide:drugs <https://nuclide.cc/drugs/pluvicto/> ;
  nuclide:institutions <https://nuclide.cc/institutions/peter-mac/> ;
  nuclide:terms <https://nuclide.cc/terms/theranostics/> ;
  nuclide:trials <https://nuclide.cc/trials/therap/>, <https://nuclide.cc/trials/propsma/> ;
  nuclide:people <https://nuclide.cc/people/hofman-michael/>, <https://nuclide.cc/people/sandhu-shahneen/> .